Donald Cutlip, MD
Enriched profileProfessor of Medicine, Harvard Medical School · Beth Israel Deaconess Medical Center
Donald Cutlip is Professor of Medicine, Harvard Medical School at Beth Israel Deaconess Medical Center. OpenAlex indexes 387 publications with 57,277 citations (h-index 89); ClinicalTrials.gov lists 4 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 1% of Interventional Cardiology profiles in the findmyKOL directory.
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
Donald Cutlip, M.D., is Professor of Medicine, Harvard Medical School at Beth Israel Deaconess Medical Center. The public record shows 387 publications with 57,277 citations (h-index 89), centered on Coronary Interventions and Diagnostics, Cardiac Imaging and Diagnostics, Acute Myocardial Infarction Research. It also documents an investigator role on 4 registered clinical trials, industry payments reported by 6 companies, 2 NIH-funded awards (2005–2013).
- Most recent indexed publication: 2026 · Circulation
- Top research focus: Coronary Interventions and Diagnostics
- 4 registered trials on ClinicalTrials.gov
- Open Payments reporting from 6 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 9 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 234.
Clinical & industry
trials, payments and federal fundingPublic positions
sourced statements on record- Publicly critiqued FDA draft guidance on drug-eluting stent clinical trials
arguing all-cause mortality and other patient-based outcomes should be reported alongside device-specific endpoints
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →pmc.ncbi.nlm.nih.gov ↗
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 4 registered studies on ClinicalTrials.gov. The most recent:
- SELUTION SLR™ 014 In-stent Restenosis
Sponsor: M.A. Med Alliance S.A.
- COBRA PZF™ Coronary Stent for Early Healing, Thrombus Inhibition, Endothelialization and Avoiding Long-Term DAPT
Sponsor: CeloNova BioSciences, Inc.
Industry payments
Updated 27 Aug 2026
6 companies reported payments to CMS in program years 2022–2025. These are public disclosures, not judgments. The latest:
- CORDIS US CORP.Program year20253 payments
- MAGENTA MEDICAL INCProgram year20251 payment
- Abbott LaboratoriesProgram year20251 payment
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
88.6%Statin18.4%Atorvastatin Calcium69%Rosuvastatin Calcium19%Pravastatin Sodium12%Part D<11 patientsBeta blocker15.5%Metoprolol Succinate91%Metoprolol Tartrate9%Part D<11 patientsBlood & clotting
11.4%Factor Xa inhibitor6.7%Eliquis100%Part D≥13 patientsP2Y12 inhibitor4.7%Clopidogrel100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 27 Aug 2026
2 NIH research awards on record, funded 2005–2013 per NIH RePORTER. The latest:
- Claudication Exercise vs Endoluminal Revascularization
Beth Israel Deaconess Medical Center
FY2012$271,671U01HL081656
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Randomized Trial of COBRA PzF Stenting to Reduce the Duration of Triple Therapy: The COBRA-REDUCE Trial.
Circulation. Cardiovascular interventions
Clinical Trial2024 - Drug-Coated Balloons in the Management of Coronary Artery Disease.
Circulation. Cardiovascular interventions
Review2024 - Acute Inflammatory Markers and Early Stent Thrombosis: Association or Causation?
Journal of the American Heart Association
Comment2024
Most-cited works
by citation count (OpenAlex)- 01Clinical End Points in Coronary Stent TrialsArticle5,427 citations2007
- 02Standardized Bleeding Definitions for Cardiovascular Clinical TrialsArticle4,465 citations2011
- 03Stenting versus Endarterectomy for Treatment of Carotid-Artery StenosisArticle2,993 citations2010
- 04Protected Carotid-Artery Stenting versus Endarterectomy in High-Risk PatientsArticle2,856 citations2004
- 05Twelve or 30 Months of Dual Antiplatelet Therapy after Drug-Eluting StentsArticle1,911 citations2014
Network
Updated 27 Aug 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/donald-cutlip-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
Mentions by others
where others cite or feature them- Other
findadoc.bidmc.org/Details/301
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →findadoc.bidmc.org ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- M.D.
University of South Florida
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →radcliffecardiology.com ↗ - Board certified
Internal Medicine-Cardiovascular Disease (American Board of Internal Medicine)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →findadoc.bidmc.org ↗
Editorial & leadership roles
journal and society appointments- Co-founder (2006)
Academic Research Consortium (standardization of endpoints/clinical trial methods for cardiac device trials)
2006verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →radcliffecardiology.com ↗ - Chief Medical Officer
Baim Institute for Clinical Research
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →baiminstitute.org ↗ - Editor-in-Chief
US Cardiology Review (Radcliffe Group)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →radcliffecardiology.com ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →scai.org ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →bostonmagazine.com ↗
Secondary affiliations
appointments beyond the home institution- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →theorg.com ↗
- Director
Cardiac Catheterization Laboratory, The Cardiovascular Institute, Beth Israel Deaconess Medical Center (role reported as current by Radcliffe Cardiology; other sources describe it as a prior role)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →radcliffecardiology.com ↗
Media & interviews
press, podcasts and appearances- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →pmc.ncbi.nlm.nih.gov ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Matcheri Keshavan, MD
Beth Israel Deaconess Medical Center
Connie Tsao, MD
Beth Israel Deaconess Medical Center
Robert Yeh, MD
Beth Israel Deaconess Medical Center
Roscoe Brady, MD
Beth Israel Deaconess Medical Center